Dexmedetomidine relieves ischaemia-reperfusion injury of kidney via up-regulation of sirtuin 3

Abstract

Abstract: Objective To study the protective effect and mechanism of dexmedetomidine (DEX) on renal ischemia-reperfusion (I/R) injury in mice. Methods The mice were divided into sham group, siRNA+sham group, renal I/R group (conventional method), DEX+I/R group (25 μg/kg DEX, intraperitoneal injection), siRNA+I/R group and siRNA+DEX+I/R group; siRNA+sham group, siRNA+I/R group and siRNA+DEX+I/R group were injected 5×10⁹ TU/kg lentivirus-sirtuin3 (SIRT3) siRNA through tail vein 3 days before surgery. Renal function was measured by biochemical analyzer, renal histomorphology was observed by HE staining, renal tissue apoptosis was detected by Tunel staining, and the expression of SIRT3, cyclophilin D (Cyp D) and cytochrome C (Cyt C) were detected by Western blot. Results DEX reduced the renal pathological damage after I/R, up-regulate the expression of SIRT3 and down-regulated the expression of Cyt C and acetylated Cyp D (P＜0.05). Inhibition of SIRT3 attenuated the protective effect of DEX on kidney. Conclusions The role of DEX in alleviating renal I/R injury may be related to the up-regulation of SIRT3.

Key words: acute kidney injury, dexmedetomidine, mitochondrial damage, sirtuin 3

CLC Number:

R965.3

WU Yue-ling, QU Hai-xia, WANG Jun-xing. Dexmedetomidine relieves ischaemia-reperfusion injury of kidney via up-regulation of sirtuin 3[J]. Basic & Clinical Medicine, 2020, 40(3): 374-379.

References

[1]Si Y, Bao H, Han L, et al. Dexmedetomidine protects against renal ischemia and reperfusion injury by inhibiting the JAK/STAT signaling activation[J]. J Transl Med, 2013, 11: 141.doi:10.1186/1479-5876-11-141.
[2]Li J, Chen Q, He X, et al. Dexmedetomidine attenuates lung apoptosis induced by renal ischemia-reperfusion injury through α2AR/PI3K/Akt pathway[J]. J Transl Med, 2018, 16:78.doi:10.1186/S12967-018-1455-1.
[3]曾敏, 杨定平, 朱凯. 线粒体Surtuin3在急性肾损伤中的作用研究进展[J]. 临床肾脏病杂志, 2018, 18: 645-648.
[4]Pi H, Xu S, Reiter RJ, et al. SIRT3-SOD2-mROS-dependent autophagy in cadmium-induced hepatotoxicity and salvage by melatonin[J]. Autophagy, 2015, 11: 1037-1051.
[5]Salvatori I, Valle C, Ferri A, et al. SIRT3 and mitochondrial metabolism in neurodegenerative diseases[J]. Neurochem Int, 2017, 109: 184-192.
[6]Guan Y, Cui ZJ, Sun B, et al. Celastrol attenuates oxidative stress in the skeletal muscle of diabetic rats by regulating the AMPK-PGC1α-SIRT3 signaling pathway[J]. Int J Mol Med, 2016, 37: 1229-1238.
[7]Koyama T, Kume S, Koya D, et al. SIRT3 attenuates palmitate-induced ROS production and inflammation in proximal tubular cells[J]. Free Radic Biol Med, 2011, 51: 1258-1267.
[8]Emma F, Montini G, Parikh SM, et al. Mitochondrial dysfunction in inherited renal disease and acute kidney injury[J]. Nat Rev Nephrol, 2016, 12: 267-280.
[9]Morigi M, Perico L, Rota C, et al. Sirtuin 3-dependent mitochondrial dynamic improvements protect against acute kidney injury[J]. J Clin Invest, 2015, 125: 715-726.
[10]Ying Y, Padanilam BJ. Regulation of necrotic cell death: p53, PARP1 and cyclophilin D-overlapping pathways of regulated necrosis[J]. Cell Mol Life Sci, 2016, 73: 2309-2324.
[11]周四桂, 徐立朋, 廖端芳, 等. 环孢霉素A通过ROS-Cyclophilin A-ERK1/2信号途径抑制人脐静脉内皮细胞与中性粒细胞粘附[J]. 生理学报, 2004, 56: 313-320.

[1]	HAN Huijing, WU Hong, GE Yin, QIAO Juan. Dexmedetomidine alleviates lung tissue injury of rat models with ventilator-associated lung injury [J]. Basic & Clinical Medicine, 2024, 44(3): 339-345.
[2]	MU Yang, YANG Zhiwen. Dexmedetomidine alleviates TNF-α-induced injury of human neuroblastoma cell line SH-SY5Y through activating AMPK [J]. Basic & Clinical Medicine, 2024, 44(2): 147-153.
[3]	LI Qingju, YU Ran, CHEN Jiajia, CHEN Haoyu, SONG Jian, WANG Wanpeng. Rapamycin attenuates ioversol-induced acute kidney injury in rat models [J]. Basic & Clinical Medicine, 2024, 44(1): 31-36.
[4]	ZHU Feng, ZHONG Yue, DENG Yijiang, LIU Wenzhi, BIAN Jiang. Dexmedetomidine ameliorates hyperalgesia of rat models with neuropathic pain via upregulation of PPAR-γ [J]. Basic & Clinical Medicine, 2023, 43(9): 1369-1374.
[5]	YAN Chen, LIU Tao, XUAN Fei. Dexmedetomidine attenuates anoxia- induced injury of human neuroblastoma cell line SH-SY5Y [J]. Basic & Clinical Medicine, 2023, 43(1): 152-158.
[6]	YUE Jian-ying, LI Ming, XI Chun-hua. Sedation effect of different regimens of dexmedetomidine in day-case ophthalmic surgery [J]. Basic & Clinical Medicine, 2022, 42(7): 1108-1112.
[7]	XU Yi-wen, LI Qing-chu. Role of Tamm-Horsfall protein in acute kidney injury [J]. Basic & Clinical Medicine, 2022, 42(11): 1795-1798.
[8]	ZHANG Xin, LIAO Xiao-hui. Role of mitochondrial dysfunction in the transition of acute renal injury to chronic kidney disease [J]. Basic & Clinical Medicine, 2021, 41(4): 589-592.
[9]	MA Tian-tian, SHI Xiao-xiao, CHEN Li-meng. Advances in the application of zebrafish in the study of acute kidney injury [J]. Basic & Clinical Medicine, 2021, 41(2): 257-261.
[10]	WU Yan, CHEN Yang, LYU Rui, ZHANG Ming, LU Kai-zhi, SHEN Jiang-hua. Effect of continuous intravenous injection of different doses of dexmedetomidine on the recovery period of general anesthesia in patients undergoing thyroid surgery [J]. Basic & Clinical Medicine, 2020, 40(8): 1037-1040.
[11]	. Activation of JNK signal pathway in kidney of mice with lipopolysaccharide induced acute kidney injury [J]. Basic & Clinical Medicine, 2015, 35(7): 951-955.
[12]	. Compensated acidosis, inflammation and etiologies are important factors influencing the prognosis of acute kidney injury [J]. Basic & Clinical Medicine, 2015, 35(5): 648-653.